Vitamin D2 has several unknown metabolites with unknown effects, and certain vitamin D receptor genotypes are big determinants of insulin secretory capacity in various ethnic groups.28, 29 Luo et al showed that among 109 patients aged over 50 years with type 2 diabetes who received cholecalciferol 2000 IU daily for 3 months, glycosylated hemoglobin concentrations and insulin use did not change significantly.30 This evidence concerns the gene VDR and type 2 diabetes mellitus.